- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
E
ENTO
Entero Therapeutics
0.35
-0.02-4.45%After Hours: 0.3751 +0.0231 +6.56%18:28 04/29 EDT
OPEN/PREV CLOSE0.3799/0.3684
TODAY RANGE0.3501-0.3799
VOL20.26K
MARKET CAP1.68M
52 WEEK RANGE0.1850-3.160
AVG VOL (3M)666.62K
% TURNOVER0.43%
TURNOVER--
P/E (TTM)-0.0661
% RANGE8.09%
EPS(TTM)-5.3277
P/E(FORWARD)-0.3115
P/B0.0290
BVPS12.16
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.64M
SHARES OUTSTANDING4.77M
NEXT EARNINGS05/12-05/16
FREE FLOAT4.65M
LOT SIZE1
EX-DIV DATE12/18/2023
News
Press Releases
Financial Reports
Profile
Benzinga·04/15 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·04/07 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·04/07 15:55
Biotech Alert: Searches spiking for these stocks today
Benzinga·04/04 12:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·04/04 09:20
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Benzinga·04/03 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·04/01 16:19
Entero Therapeutics Delays 10-K Filing
Seeking Alpha·03/25 08:11
Entero Therapeutics slips 7%, signs rescission agreement with ImmunogenX
Dow Jones·03/13 12:33
*Vicarious Surgical: Romano Last Served as CFO of Entero Therapeutics >RBOT
TipRanks·03/05 17:16
Biotech Alert: Searches spiking for these stocks today
Seeking Alpha·02/14 21:10
Entero Therapeutics appoints interim CEO
TipRanks·02/14 21:06
Entero Therapeutics names Richard Paolone as interim CEO
Dow Jones·02/14 21:00
Press Release: Entero Therapeutics Appoints Richard Paolone as CEO
TipRanks·02/07 20:40
Entero Therapeutics secures $2M revolving loan, appoints three new directors
Same Industry
Name/Symbol
Change%
Price